Celebrex™ (Celecoxib) and chemoradiation in patients with locally advanced cervical cancer.: An efficacy report of RTOG 0128

被引：0
|
作者：
Gaffney, D. K.
Winter, K.
Dicker, A. P.
Miller, B.
Eifel, P. J.
Ryu, J.
Avizonis, V.
Fromm, M.
Greven, K.
机构：
[1] Univ Utah, Huntsman Canc Hosp, Salt Lake City, UT USA
[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA
[3] Thomas Jefferson Univ Hosp, Bodine Ctr Canc Treatment, Philadelphia, PA 19107 USA
[4] Wake Forest Univ, Winston Salem, NC 27109 USA
[5] M D Anderson Canc Ctr, Houston, TX USA
[6] Calif State Univ Sacramento, Davis Canc Ctr, Sacramento, CA 95819 USA
[7] LDS Hosp Radiat Ctr, Salt Lake City, UT USA
[8] Akron Gen Med Ctr, Akron, OH USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] A phase II study of acute toxicity for celebrex™ (celecoxib) and chemoradiation in patients with locally advanced cervical cancer:: Primary endpoint analysis of RTOG 0128
    Gaffney, David K.
    Winter, Kathryn
    Dicker, Adam P.
    Miller, Brigitte
    Eifel, Patricia J.
    Ryu, Janice
    Avizonis, Vilija
    Fromm, Mitch
    Greven, Kathryn
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 104 - 109
  • [2] Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in rtog 0128
    Gaffney, David K.
    Winter, Kathryn
    Dicker, Adam P.
    Miller, Brigitte
    Eifel, Patricia J.
    Ryu, Janice
    Avizonis, Vilija
    Fromm, Mitch
    Small, William
    Greven, Kathryn
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (01): : 111 - 117
  • [3] A phase I-II study of COX-2 inhibitor, Celebrex (Celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128
    Gaffney, DK
    Winter, K
    Dicker, A
    Miller, B
    Jhingran, A
    Ryu, J
    Avizonis, V
    Fromm, M
    Greven, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S93 - S94
  • [4] Phase II study of the preoperative use of celecoxib (CELEBREX™) and FEC for the treatment of locally advanced breast cancer.
    Chow, LWC
    Toi, M
    Takebayashi, Y
    Sasano, H
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S51 - S51
  • [5] Prospective pilot study of the preoperative use of celecoxib (Celebrex™) and FEC for the treatment of locally advanced breast cancer.
    Chow, LWC
    Toi, M
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S54 - S54
  • [6] Efficacy and toxicity of chemoradiation with brachytherapy for locally advanced cervical cancer
    Horeweg, N.
    Creutzberg, C. L.
    Rijkmans, E. C.
    Laman, M. S.
    Velema, L. A.
    Coen, V. L. M. A.
    Stam, T. C.
    Kerkhof, E. M.
    Kroep, J. R.
    De Kroon, C. D.
    Nout, R. A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S420 - S421
  • [7] ERCC1, COX-2, and p53 expression in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: A quantitative immunohistochemical analysis of RTOG 0128
    Doll, C. M.
    Winter, K.
    Gaffney, D. K.
    Ryu, J.
    Jhingran, A.
    Dicker, A. P.
    Weidhaas, J. B.
    Miller, B. E.
    Magliocco, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S355 - S356
  • [8] Predictors of radiation field failure after definitive chemoradiation in patients with locally advanced cervical cancer.
    Bae, Hyo Sook
    Kim, Yeon-Joo
    Lim, Myong Cheol
    Seo, Sang-Soo
    Park, Sang-Yoon
    Kang, Sokbom
    Kim, Sun Ho
    Kim, Joo-Young
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] A randomized phase II study of chemoradiation and pembrolizumab for locally advanced cervical cancer.
    Duska, Linda R.
    Showalter, Timothy Norman
    Petroni, Gina R.
    Bullock, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Adjuvant chemotherapy after concurrent chemoradiation therapy for locally advanced cervical cancer.
    Kou, Lingna
    Zhang, Tao
    Peng, Siyun
    Wang, Yifei
    Yuan, Mingyang
    Li, Minmin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345